1887

Abstract

The protease activity of the hepatitis C virus (HCV) NS3 protein has been investigated using transient expression methods in mammalian cells, as well as transcription/translation systems. We confirmed that expression of the NS3−5 polyprotein in rabbit reticulocyte lysates results in efficient cis processing at the NS3/NS4 junction. However, processing at the other predicted sites of NS3-mediated cleavage varied markedly in efficiency, the site most susceptible being that between NS5A and NS5B. Time-course analysis of the proteolytic processing of the HCV non-structural precursor showed that the cis cleavage between NS3 and NS4 occurred extremely rapidly. However, efficient cleavage at this position was dependent on the prior removal of the NS2 protein. Furthermore, the presence of uncleaved NS2 sequences on the enzyme severely impeded NS3-mediated proteolysis at downstream sites in the polyprotein. This suggests therefore that efficient cleavage at the NS2/NS3 junction is a pivotal event in HCV replication. During the course of this study a proteolytically inactive mutant of NS3 was characterized carrying a previously unreported amino acid substitution near the proposed active site of the enzyme. Molecular modelling suggested that the amino acid present at this position may influence the conformation of the active site of the enzyme. Recently a number of reports have described a second protease activity, located in the NS2/NS3 region, which is responsible for cleavage at the NS2/NS3 junction. We have identified an isolate of HCV, obtained from a U.K. patient, which has a virtually inactive NS2/NS3 protease. The possible implications of this observation are discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-12-3469
1994-12-01
2021-10-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/12/JV0750123469.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-12-3469&mimeType=html&fmt=ahah

References

  1. Alter H. J. 1989; Chronic consequences of non-A, non-B hepatitis. In Current Perspectives in Hepatology pp. 83–97 Seef L. B., Lewis J. H. Edited by New York: Plenum;
    [Google Scholar]
  2. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q.-L., Kuo G. 1989; Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321:1494–1500
    [Google Scholar]
  3. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. 1993; Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. Journal of Virology 67:3835–3844
    [Google Scholar]
  4. Bukh J., Miller R. H., Kew M. C., Purcell R. H. 1993; Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proceedings of the National Academy of Sciences, U.S.A 901848–1851
    [Google Scholar]
  5. Cahour A., Falgout B., Lai C. J. 1992; Cleavage of the dengue virus polyprotein at the NS3/NS4a and NS4b/NS5 junctions is mediated by viral protease NS2b-NS3 whereas NS4a/NS4b may be processed by a cellular protease. Journal of Virology 66:1535–1542
    [Google Scholar]
  6. Chambers T. J., Weir R. C., Grakoui A., McCourt D. W., Bazan F. F., Fletterick R. J., Rice C. M. 1990; Evidence that the N-terminal domain of non-structural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proceedings of the National Academy of Sciences, U.S.A 878898–8902
    [Google Scholar]
  7. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
    [Google Scholar]
  8. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C. , Coit D., Medina Selby R., Barr P. J. 1991; Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, U.S.A 882451–2455
    [Google Scholar]
  9. Clarke B. E., Sangar D. V. 1988; Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA. Journal of General Virology 69:2313–2325
    [Google Scholar]
  10. Davis G. L., Lindsay K., Albrecht J., Bodenheimer H. C., Balart L. A., Perrillo R. P., Dienstag J. L., Tamburro C., Schiff E. R., Carey W., Payne J., Jacobson I. M., Van Thiel D. H., Lefkowitch J. Hepatitis Interventional Therapy Group 1990a; Predictors of response to recombinant alpha interferon(rlFN) treatment in patients with chronic hepatitis C. Hepatology 12:905
    [Google Scholar]
  11. Davis G. L., Balart L. A., Schiff E. R., Lindsay K., Bodenheimer H. C., Perrillo R. P., Carey W., Jacobson I. M., Payne J., Dienstag J. L., Van Thiel D. H., Tamburra C., Lefkowitch J., Albrecht J., Meschievitz C., Ortego T. J., Gibas A. 1990b; Treatment of chronic hepatitis C with recombinant interferon alpha: a randomized double-blind, placebo-controlled trial. New England Journal of Medicine 321:1501–1506
    [Google Scholar]
  12. Di Bisceglie A. M., Hoofnagle J. H. 1991; Therapy of chronic hepatitis C with alpha interferon: The answer? Or more questions?. Hepatology 13:601–603
    [Google Scholar]
  13. Di Bisceglie A. M., Shindo M., Fong T.-L., Fried M. W., Swain M. G., Bergasa N. V., Axiotis C. A., Waggoner J. G., Park Y. 1992; A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 16:649–654
    [Google Scholar]
  14. Dienstag J. L., Alter H. J. 1986; Non-A, non-B hepatitis evolving epidemiologic and clinical perspectives. Seminars in Liver Disease 6:67–81
    [Google Scholar]
  15. Eckart M. R., Selby M., Masiarz F., Lee C., Berger K., Crawford K., Kuo G., Fioughton M., Choo Q.-L. 1993; The hepatitis C virus encodes a serine protease involved in processing of the putative non-structural proteins from the viral polyprotein precursor. Biochemical and Biophysical Research Communications 192:399–406
    [Google Scholar]
  16. Gorbalenya A. E., Koonin E. V., Donchenko A. P., Blinov V. M. 1989; Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Research 17:4713–4729
    [Google Scholar]
  17. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993a; Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites. Journal of Virology 67:2832–2843
    [Google Scholar]
  18. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. 1993b; Expression and identification of hepatitis C virus polyprotein cleavage products. Journal of Virology 67:1385–1395
    [Google Scholar]
  19. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993c; A second hepatitis C virus-encoded protease. Proceedings of the National Academy of Sciences U.S.A: 9010583–10587
    [Google Scholar]
  20. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. 1991; Gene mapping of the putative structural region of the hepatitis C virus genome by in vitroprocessing analysis. Proceedings of the National Academy of Sciences, U.S.A 885547–5551
    [Google Scholar]
  21. Fiijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohmo K. 1993; Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. Journal of Virology 67:4665–4675
    [Google Scholar]
  22. Kakumu S., Yoshioka K., Wakita T., Ishikawa T., Takayanagi M., Fiigashi Y. 1993; A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507–512
    [Google Scholar]
  23. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, U.S.A 879524–9528
    [Google Scholar]
  24. Kettinen H., Grace K., Grunert S., Clarke B., Rowlands D., Jackson R. 1993; Mapping of the internal ribosome entry site at the 5′ end of the hepatitis C virus genome. In Proceedings of ISVHLD 1993 Tokyo: pp. 125–131 Nishioka K., Suzuki H., Mishiro S., Oda T. Edited by Springer-Verlag;
    [Google Scholar]
  25. Kuo G., Choo Q.-L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E., Tegtmeyer G. E., Bonino F., Colombo M., Lee W-E., Kuo C., Berger K., Shuster J. R., Overby L. R., Bradley D. W., Houghton M. 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
    [Google Scholar]
  26. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  27. Lindsay K. L., Davis G. L., Bodenheimer H. C., Albrecht J., Balart L. A., Perrillo R. P., Dienstag J. L., Tamburro C., Schiff E. R., Carey W., Payne J., Jacobson I. M., Van Thiel D. H., Lefkowitch J.Hepatitis Interventional Therapy Group 1990; Predictors of relapse and response to re-treatment in patients with an initial response to recombinant alpha interferon (rIFN) therapy for chronic hepatitis C. Hepatology 12847
    [Google Scholar]
  28. Miller R. H., Purcell R. H. 1990; Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proceedings of the National Academy of Sciences, U.S.A 872057–2061
    [Google Scholar]
  29. Pappas S. C., Hoofnagle J. H., Young N., Straus S. E., Jones E. A. 1984; Treatment of chronic non-A, non-B hepatitis with acyclovir: a pilot study. Journal of Medical Virology 15:1–9
    [Google Scholar]
  30. Pizzi E., Tramontano A., Tomei L., Lamonica N., Failla C., Sardana M., Wood T., De Francesco R. 1994; Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proceedings of the National Academy of Sciences, U.S.A 91888–892
    [Google Scholar]
  31. Renault P. F., Hoofnagle J. H. 1989; Side effects of alpha interferon. Seminars in Liver Disease 9:273–277
    [Google Scholar]
  32. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe T. Y., Koi S., Onji M., Ohta Y., Choo Q.-L., Houghton M., Kuo G. 1990; Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences, U.S.A 876547–6549
    [Google Scholar]
  33. Stokes P., Lopez W. C., Balart L. A. 1987; Effects of short term corticosteroid therapy in patients with chronic non-A, non-B hepatitis (NANB). (abst). Gastroenterology 92:1783
    [Google Scholar]
  34. Suzich J. A., Tamura J. K., Palmer-Hill F., Warrener P., Grakoui A., Rice C. M., Feinstone S. M., Collett M. S. 1993; Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. Journal of Virology 67:6152–6158
    [Google Scholar]
  35. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. 1991; Structure and organization of the hepatitis C virus genome isolated from human carriers. Journal of Virology 65:1105–1113
    [Google Scholar]
  36. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. 1993; NS3 is a serine protease required for processing of hepatitis C virus polyprotein. Journal of Virology 67:4017–1026
    [Google Scholar]
  37. Tsukiyama-Kohara K., Iizuka N., Kohara M., Nomoto A. 1992; Internal ribosome entry site within hepatitis C virus RNA. Journal of Virology 66:1476–1483
    [Google Scholar]
  38. Wang C., Sarnow P., Siddiqui A. 1993; Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. Journal of Virology 67:3338–3344
    [Google Scholar]
  39. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q. L., Houghton M. 1991; Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842–848
    [Google Scholar]
  40. Wiskerchen M., Collett M. S. 1991; Pestivirus gene expression: protein p80 of bovine viral diarrhoea virus is a proteinase involved in polyprotein processing. Virology 184:341–350
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-12-3469
Loading
/content/journal/jgv/10.1099/0022-1317-75-12-3469
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error